Burden of peripheral arterial disease in Europe and the United States: a patient survey
Open Access
- 22 October 2013
- journal article
- Published by Springer Science and Business Media LLC in Health and Quality of Life Outcomes
- Vol. 11 (1), 175
- https://doi.org/10.1186/1477-7525-11-175
Abstract
Background The aim of the current study was to quantify the burden of peripheral arterial disease (PAD) with respect to health-related quality of life, work productivity and activity impairment, and healthcare resource utilization. Methods Data were obtained from the 2010 EU National Health and Wellness Survey (NHWS), which included participants from France, Germany, Italy, Spain, and the UK (5EU, N = 57,805) as well as the 2010 US NHWS (N = 75,000). The NHWS is an annual, cross-sectional, self-administered Internet survey which employs a stratified random sampling frame to match the age and gender characteristics of the NHWS sample with known population statistics. Participants who self-reported a diagnosis of PAD were compared with participants who did not self-report a diagnosis of PAD on health-related quality of life (mental and physical component summary scores and health utilities from the Short Form-12v2), work productivity and activity impairment (Work Productivity and Activity Impairment questionnaire), and healthcare resource use in terms of the number of physician visits, emergency room visits, and hospitalizations in the past six months through regression modeling adjusting for demographics and health characteristics. Results A total of 743 (1.29%) and 777 (1.04%) participants self-reported a diagnosis of PAD in the 5EU and US, respectively. After adjusting for demographics and health characteristics, patients with PAD reported worse health-related quality of life, as measured by health utilities (5EU: 0.66 vs. 0.70; US: 0.66 vs. 0.72; all p < .05), greater overall work impairment percentage (5EU: 38.27% vs. 27.48%; US: 23.89% vs. 14.26%) and greater healthcare resource use compared to participants without PAD (all p < .05). Conclusions These results suggest a significant burden for patients with PAD in both the 5 EU countries and the US with respect to both quality of life and economic outcomes. Improved management of these patients may have profound effects from both patient and societal perspectives.Keywords
This publication has 30 references indexed in Scilit:
- Vaccination Rates among the General Adult Population and High-Risk Groups in the United StatesPLOS ONE, 2012
- The Effects of Including Quality of Life Responses in Models to Predict Walking Performance of Patients with Intermittent ClaudicationEuropean Journal of Vascular and Endovascular Surgery, 2011
- Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United StatesCirculation: Cardiovascular Quality and Outcomes, 2010
- Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and ManagementMayo Clinic Proceedings, 2010
- The Peripheral Arterial disease study (PERART/ARTPER): prevalence and risk factors in the general populationBMC Public Health, 2010
- Functional claudication distance: a reliable and valid measurement to assess functional limitation in patients with intermittent claudicationBMC Cardiovascular Disorders, 2009
- Management of Peripheral Arterial DiseaseCardiology in Review, 2005
- Quality of life after infrainguinal bypass grafting surgeryJournal of Vascular Surgery, 1999
- The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987